Skip to main content
. 2019 Jan 29;2019(1):CD003331. doi: 10.1002/14651858.CD003331.pub5

2. Costs and cost‐effectiveness.

Author (year) Georgiou (2001) HF‐ACTION
Reed (2010)
Witham (2012) Cowie (2014) Centre and home Dalal (2018) Lang (2018)
Year of costs
Country
Currency
1998
US
USD
2008
US
USD
2010
UK
GBP
2013/2014
UK
GBP
2016
UK
GBP
2016
UK
GBP
Intervention cost      
Mean costs/patient 4,563 6,483 (SD 4,884) 474.75 Not reported 418.39 362.61
Costs considered Staffing, space rental, equipment, patients’ lost wages Staffing, patient time, travel, parking Staffing, equipment, staff and patient travel Staffing, equipment, consumables*
(*home training only)
Primary and secondary care, social care, drugs, NHS and intervention costs Staffing, equipment, staff travel
Cost‐effectiveness      
Follow‐up period 15.5 years Mean 2.5 years 6 months 5 years NR NR
Total mean healthcare cost/patient
(exercise)
5,282* 57,338 (SD 81,343)+ 1888.24 (SD 3111) 221.58 (hospital) and 196.53 (home) NR NR
Total mean healthcare costs per
patient (control)
2,055* 56,177 (SD 92,749)+ 1943.93 (SD 4551) Not calculated NR NR
Incremental healthcare costs 3227* 1,161 (95% CI ‐6,205 to 8,404) ‐447.85 (95% CI ‐1696.00 to 931.00) NR NR NR
Additional healthcare costs
considered
Hospitalisations Medication, procedures, outpatient visits, emergency visits, hospitalisations, tests Inpatient and outpatient admissions, primary care contacts, medication NR NR NR
Mean healthcare benefit (exercise) 10.24 life‐years 2.02 QALYs (SD 1.00) NR NR 0.74 QALYs (SD 0.22) NR
Mean health care benefit (control) 7.96 life‐years 1.99 QALYs (SD 1.01) NR NR 0.76 QALYs (SD 0.21) NR
Incremental mean healthcare benefit 1.82 life‐years 0.03 (95% CI ‐0.06 to 0.11) NR NR NR NR
Incremental cost‐effectiveness ratio 1,773 per life‐year saved NR NR NR NR NR

CI: confidence interval; GBP: GB pounds; NR: not reported; QALY: quality‐adjusted life year; SD: standard deviation; USD: US dollars.

HHS Vulnerability Disclosure